0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Plasma-derived Factor VIII - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-39D12137
Home | Market Reports | Health| Pharmacy
Global Plasma derived Factor VIII Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Plasma-derived Factor VIII - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39D12137
Report
September 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plasma-derived Factor VIII - Market Size

The global market for Plasma-derived Factor VIII was estimated to be worth US$ 8761 million in 2023 and is forecast to a readjusted size of US$ 12950 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030

Plasma-derived Factor VIII - Market

Plasma-derived Factor VIII - Market

RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A. 
The market growth can be attributed to several factors. Firstly, the increasing prevalence of hemophilia A and the rising awareness about the importance of early diagnosis and treatment have led to a growing demand for Factor VIII products. The availability of plasma-derived Factor VIII provides an effective treatment option for patients who require clotting factor replacement therapy. Secondly, advancements in manufacturing techniques and purification processes have improved the safety and efficacy of plasma-derived Factor VIII products. Stringent regulatory standards and guidelines for plasma collection and fractionation have instilled confidence among healthcare providers and patients regarding the safety of these products.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plasma-derived Factor VIII, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Plasma-derived Factor VIII by region & country, by Type, and by Application.
The Plasma-derived Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma-derived Factor VIII.
Market Segmentation

Scope of Plasma-derived Factor VIII - Market Report

Report Metric Details
Report Name Plasma-derived Factor VIII - Market
Forecasted market size in 2030 US$ 12950 million
CAGR 5.7%
Forecasted years 2024 - 2030
Segment by Type:
  • 200IU
  • 250IU
Segment by Application
  • Hospital
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, Octapharma, CSL, Grifols, Greencross, Kedrion, BPL, Hualan Bio, RAAS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Plasma-derived Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Plasma-derived Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Plasma-derived Factor VIII in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Plasma-derived Factor VIII - Market size in 2030?

Ans: The Plasma-derived Factor VIII - Market size in 2030 will be US$ 12950 million.

Who are the main players in the Plasma-derived Factor VIII - Market report?

Ans: The main players in the Plasma-derived Factor VIII - Market are Takeda, Octapharma, CSL, Grifols, Greencross, Kedrion, BPL, Hualan Bio, RAAS

What are the Application segmentation covered in the Plasma-derived Factor VIII - Market report?

Ans: The Applications covered in the Plasma-derived Factor VIII - Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Plasma-derived Factor VIII - Market report?

Ans: The Types covered in the Plasma-derived Factor VIII - Market report are 200IU, 250IU

Recommended Reports

Coagulation and Hemostasis

Plasma-based Therapy

Hemophilia and Related Disorders

1 Market Overview
1.1 Plasma-derived Factor VIII Product Introduction
1.2 Global Plasma-derived Factor VIII Market Size Forecast
1.2.1 Global Plasma-derived Factor VIII Sales Value (2019-2030)
1.2.2 Global Plasma-derived Factor VIII Sales Volume (2019-2030)
1.2.3 Global Plasma-derived Factor VIII Sales Price (2019-2030)
1.3 Plasma-derived Factor VIII Market Trends & Drivers
1.3.1 Plasma-derived Factor VIII Industry Trends
1.3.2 Plasma-derived Factor VIII Market Drivers & Opportunity
1.3.3 Plasma-derived Factor VIII Market Challenges
1.3.4 Plasma-derived Factor VIII Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Plasma-derived Factor VIII Players Revenue Ranking (2023)
2.2 Global Plasma-derived Factor VIII Revenue by Company (2019-2024)
2.3 Global Plasma-derived Factor VIII Players Sales Volume Ranking (2023)
2.4 Global Plasma-derived Factor VIII Sales Volume by Company Players (2019-2024)
2.5 Global Plasma-derived Factor VIII Average Price by Company (2019-2024)
2.6 Key Manufacturers Plasma-derived Factor VIII Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Plasma-derived Factor VIII Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Plasma-derived Factor VIII
2.9 Plasma-derived Factor VIII Market Competitive Analysis
2.9.1 Plasma-derived Factor VIII Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Plasma-derived Factor VIII Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Factor VIII as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 200IU
3.1.2 250IU
3.2 Global Plasma-derived Factor VIII Sales Value by Type
3.2.1 Global Plasma-derived Factor VIII Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Plasma-derived Factor VIII Sales Value, by Type (2019-2030)
3.2.3 Global Plasma-derived Factor VIII Sales Value, by Type (%) (2019-2030)
3.3 Global Plasma-derived Factor VIII Sales Volume by Type
3.3.1 Global Plasma-derived Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Plasma-derived Factor VIII Sales Volume, by Type (2019-2030)
3.3.3 Global Plasma-derived Factor VIII Sales Volume, by Type (%) (2019-2030)
3.4 Global Plasma-derived Factor VIII Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Plasma-derived Factor VIII Sales Value by Application
4.2.1 Global Plasma-derived Factor VIII Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Plasma-derived Factor VIII Sales Value, by Application (2019-2030)
4.2.3 Global Plasma-derived Factor VIII Sales Value, by Application (%) (2019-2030)
4.3 Global Plasma-derived Factor VIII Sales Volume by Application
4.3.1 Global Plasma-derived Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Plasma-derived Factor VIII Sales Volume, by Application (2019-2030)
4.3.3 Global Plasma-derived Factor VIII Sales Volume, by Application (%) (2019-2030)
4.4 Global Plasma-derived Factor VIII Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Plasma-derived Factor VIII Sales Value by Region
5.1.1 Global Plasma-derived Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Plasma-derived Factor VIII Sales Value by Region (2019-2024)
5.1.3 Global Plasma-derived Factor VIII Sales Value by Region (2025-2030)
5.1.4 Global Plasma-derived Factor VIII Sales Value by Region (%), (2019-2030)
5.2 Global Plasma-derived Factor VIII Sales Volume by Region
5.2.1 Global Plasma-derived Factor VIII Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Plasma-derived Factor VIII Sales Volume by Region (2019-2024)
5.2.3 Global Plasma-derived Factor VIII Sales Volume by Region (2025-2030)
5.2.4 Global Plasma-derived Factor VIII Sales Volume by Region (%), (2019-2030)
5.3 Global Plasma-derived Factor VIII Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Plasma-derived Factor VIII Sales Value, 2019-2030
5.4.2 North America Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Plasma-derived Factor VIII Sales Value, 2019-2030
5.5.2 Europe Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Plasma-derived Factor VIII Sales Value, 2019-2030
5.6.2 Asia Pacific Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Plasma-derived Factor VIII Sales Value, 2019-2030
5.7.2 South America Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Plasma-derived Factor VIII Sales Value, 2019-2030
5.8.2 Middle East & Africa Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Plasma-derived Factor VIII Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Plasma-derived Factor VIII Sales Value
6.2.1 Key Countries/Regions Plasma-derived Factor VIII Sales Value, 2019-2030
6.2.2 Key Countries/Regions Plasma-derived Factor VIII Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Plasma-derived Factor VIII Sales Value, 2019-2030
6.3.2 United States Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Plasma-derived Factor VIII Sales Value, 2019-2030
6.4.2 Europe Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Plasma-derived Factor VIII Sales Value, 2019-2030
6.5.2 China Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.5.3 China Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Plasma-derived Factor VIII Sales Value, 2019-2030
6.6.2 Japan Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Plasma-derived Factor VIII Sales Value, 2019-2030
6.7.2 South Korea Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Plasma-derived Factor VIII Sales Value, 2019-2030
6.8.2 Southeast Asia Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Plasma-derived Factor VIII Sales Value, 2019-2030
6.9.2 India Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
6.9.3 India Plasma-derived Factor VIII Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Takeda Plasma-derived Factor VIII Product Offerings
7.1.5 Takeda Recent Development
7.2 Octapharma
7.2.1 Octapharma Company Information
7.2.2 Octapharma Introduction and Business Overview
7.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Octapharma Plasma-derived Factor VIII Product Offerings
7.2.5 Octapharma Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Introduction and Business Overview
7.3.3 CSL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CSL Plasma-derived Factor VIII Product Offerings
7.3.5 CSL Recent Development
7.4 Grifols
7.4.1 Grifols Company Information
7.4.2 Grifols Introduction and Business Overview
7.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Grifols Plasma-derived Factor VIII Product Offerings
7.4.5 Grifols Recent Development
7.5 Greencross
7.5.1 Greencross Company Information
7.5.2 Greencross Introduction and Business Overview
7.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Greencross Plasma-derived Factor VIII Product Offerings
7.5.5 Greencross Recent Development
7.6 Kedrion
7.6.1 Kedrion Company Information
7.6.2 Kedrion Introduction and Business Overview
7.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Kedrion Plasma-derived Factor VIII Product Offerings
7.6.5 Kedrion Recent Development
7.7 BPL
7.7.1 BPL Company Information
7.7.2 BPL Introduction and Business Overview
7.7.3 BPL Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.7.4 BPL Plasma-derived Factor VIII Product Offerings
7.7.5 BPL Recent Development
7.8 Hualan Bio
7.8.1 Hualan Bio Company Information
7.8.2 Hualan Bio Introduction and Business Overview
7.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hualan Bio Plasma-derived Factor VIII Product Offerings
7.8.5 Hualan Bio Recent Development
7.9 RAAS
7.9.1 RAAS Company Information
7.9.2 RAAS Introduction and Business Overview
7.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue and Gross Margin (2019-2024)
7.9.4 RAAS Plasma-derived Factor VIII Product Offerings
7.9.5 RAAS Recent Development
8 Industry Chain Analysis
8.1 Plasma-derived Factor VIII Industrial Chain
8.2 Plasma-derived Factor VIII Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Plasma-derived Factor VIII Sales Model
8.5.2 Sales Channel
8.5.3 Plasma-derived Factor VIII Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Plasma-derived Factor VIII Market Trends
    Table 2. Plasma-derived Factor VIII Market Drivers & Opportunity
    Table 3. Plasma-derived Factor VIII Market Challenges
    Table 4. Plasma-derived Factor VIII Market Restraints
    Table 5. Global Plasma-derived Factor VIII Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Plasma-derived Factor VIII Revenue Market Share by Company (2019-2024)
    Table 7. Global Plasma-derived Factor VIII Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Plasma-derived Factor VIII Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Plasma-derived Factor VIII Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Plasma-derived Factor VIII Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Plasma-derived Factor VIII Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Plasma-derived Factor VIII
    Table 13. Global Plasma-derived Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Factor VIII as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Plasma-derived Factor VIII Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Plasma-derived Factor VIII Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Plasma-derived Factor VIII Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Plasma-derived Factor VIII Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Plasma-derived Factor VIII Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Plasma-derived Factor VIII Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Plasma-derived Factor VIII Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Plasma-derived Factor VIII Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Plasma-derived Factor VIII Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Plasma-derived Factor VIII Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Plasma-derived Factor VIII Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Plasma-derived Factor VIII Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Plasma-derived Factor VIII Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Plasma-derived Factor VIII Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Plasma-derived Factor VIII Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Plasma-derived Factor VIII Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Plasma-derived Factor VIII Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Plasma-derived Factor VIII Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Plasma-derived Factor VIII Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Plasma-derived Factor VIII Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Plasma-derived Factor VIII Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Plasma-derived Factor VIII Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Plasma-derived Factor VIII Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Plasma-derived Factor VIII Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Plasma-derived Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Plasma-derived Factor VIII Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Plasma-derived Factor VIII Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Plasma-derived Factor VIII Sales Value by Region (2019-2024) & (%)
    Table 44. Global Plasma-derived Factor VIII Sales Value by Region (2025-2030) & (%)
    Table 45. Global Plasma-derived Factor VIII Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Plasma-derived Factor VIII Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Plasma-derived Factor VIII Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Plasma-derived Factor VIII Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Plasma-derived Factor VIII Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Plasma-derived Factor VIII Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Plasma-derived Factor VIII Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Plasma-derived Factor VIII Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Plasma-derived Factor VIII Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Plasma-derived Factor VIII Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Plasma-derived Factor VIII Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Plasma-derived Factor VIII Sales Volume, (2025-2030) & (K Units)
    Table 57. Takeda Company Information
    Table 58. Takeda Introduction and Business Overview
    Table 59. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Takeda Plasma-derived Factor VIII Product Offerings
    Table 61. Takeda Recent Development
    Table 62. Octapharma Company Information
    Table 63. Octapharma Introduction and Business Overview
    Table 64. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Octapharma Plasma-derived Factor VIII Product Offerings
    Table 66. Octapharma Recent Development
    Table 67. CSL Company Information
    Table 68. CSL Introduction and Business Overview
    Table 69. CSL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. CSL Plasma-derived Factor VIII Product Offerings
    Table 71. CSL Recent Development
    Table 72. Grifols Company Information
    Table 73. Grifols Introduction and Business Overview
    Table 74. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Grifols Plasma-derived Factor VIII Product Offerings
    Table 76. Grifols Recent Development
    Table 77. Greencross Company Information
    Table 78. Greencross Introduction and Business Overview
    Table 79. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Greencross Plasma-derived Factor VIII Product Offerings
    Table 81. Greencross Recent Development
    Table 82. Kedrion Company Information
    Table 83. Kedrion Introduction and Business Overview
    Table 84. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Kedrion Plasma-derived Factor VIII Product Offerings
    Table 86. Kedrion Recent Development
    Table 87. BPL Company Information
    Table 88. BPL Introduction and Business Overview
    Table 89. BPL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. BPL Plasma-derived Factor VIII Product Offerings
    Table 91. BPL Recent Development
    Table 92. Hualan Bio Company Information
    Table 93. Hualan Bio Introduction and Business Overview
    Table 94. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Hualan Bio Plasma-derived Factor VIII Product Offerings
    Table 96. Hualan Bio Recent Development
    Table 97. RAAS Company Information
    Table 98. RAAS Introduction and Business Overview
    Table 99. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. RAAS Plasma-derived Factor VIII Product Offerings
    Table 101. RAAS Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Plasma-derived Factor VIII Downstream Customers
    Table 105. Plasma-derived Factor VIII Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Plasma-derived Factor VIII Product Picture
    Figure 2. Global Plasma-derived Factor VIII Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Plasma-derived Factor VIII Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Plasma-derived Factor VIII Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Plasma-derived Factor VIII Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Plasma-derived Factor VIII Report Years Considered
    Figure 7. Global Plasma-derived Factor VIII Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Plasma-derived Factor VIII Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma-derived Factor VIII Revenue in 2023
    Figure 10. Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 200IU Picture
    Figure 12. 250IU Picture
    Figure 13. Global Plasma-derived Factor VIII Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Plasma-derived Factor VIII Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Plasma-derived Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Plasma-derived Factor VIII Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Plasma-derived Factor VIII Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Pharmacy
    Figure 20. Global Plasma-derived Factor VIII Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Plasma-derived Factor VIII Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Plasma-derived Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Plasma-derived Factor VIII Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Plasma-derived Factor VIII Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Plasma-derived Factor VIII Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Plasma-derived Factor VIII Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Plasma-derived Factor VIII Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Plasma-derived Factor VIII Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Plasma-derived Factor VIII Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Plasma-derived Factor VIII Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Plasma-derived Factor VIII Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Plasma-derived Factor VIII Sales Volume (%), (2019-2030)
    Figure 37. United States Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Plasma-derived Factor VIII Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Plasma-derived Factor VIII Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Plasma-derived Factor VIII Sales Value by Application (%), 2023 VS 2030
    Figure 58. Plasma-derived Factor VIII Industrial Chain
    Figure 59. Plasma-derived Factor VIII Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart